These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2505299)

  • 1. Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.
    Tan S; Kirk RC; Abraham WC; McNaughton N
    Psychopharmacology (Berl); 1989; 98(4):556-60. PubMed ID: 2505299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.
    Ward L; Mason SE; Abraham WC
    Pharmacol Biochem Behav; 1990 Apr; 35(4):785-90. PubMed ID: 2189143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.
    Tang AH; Ho PM
    Eur J Pharmacol; 1988 Jun; 151(1):143-6. PubMed ID: 3046954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.
    Butelman ER
    Pharmacol Biochem Behav; 1989 Sep; 34(1):13-6. PubMed ID: 2696982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
    France CP; Woods JH; Ornstein P
    Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.
    Cole BJ; Klewer M; Jones GH; Stephens DN
    Psychopharmacology (Berl); 1993; 111(4):465-71. PubMed ID: 7870988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-methyl-D-aspartate antagonists on the cough reflex.
    Kamei J; Tanihara H; Igarashi H; Kasuya Y
    Eur J Pharmacol; 1989 Sep; 168(2):153-8. PubMed ID: 2691260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626.
    Willetts J; Bobelis DJ; Balster RL
    Psychopharmacology (Berl); 1989; 99(4):458-62. PubMed ID: 2687923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological selectivity of three NMDA antagonists.
    Childs AM; Evans RH; Watkins JC
    Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
    Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
    J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
    Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
    Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
    Willetts J; Balster RL
    Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of N-methyl-D-aspartate antagonists on the development of vestibular compensation in the guinea pig.
    Darlington CL; Smith PF
    Eur J Pharmacol; 1989 Dec; 174(2-3):273-8. PubMed ID: 2698350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.